Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Nephrology · IgA Nephropathy and IgA Vasculitis

IgA Nephropathy vs. IgA Vasculitis: What's Different?

At a Glance

IgA nephropathy usually affects the kidneys alone, while IgA vasculitis can also cause a raised purple-red rash, joint symptoms, and digestive problems. Kidney biopsies may look alike, so doctors use your symptoms, examination, and follow-up tests to tell them apart.

The main difference between primary IgA nephropathy (IgAN) and IgA vasculitis (IgAV) with kidney involvement is where the disease is active in your body. It is completely understandable to feel confused when two different conditions share similar kidney biopsy results.

Primary IgA nephropathy is a condition that is generally limited to the kidneys [1]. IgA vasculitis (formerly known as Henoch-Schönlein purpura) is a systemic condition—meaning it affects multiple systems in the body, typically involving the skin, joints, and gastrointestinal (GI) tract, in addition to the kidneys [2]. Because the kidney damage in both conditions overlaps substantially under a microscope, doctors rely on your full-body symptoms, medical history, and physical examination to tell them apart [3].

Why the Kidney Biopsy Isn’t Enough

If you undergo a kidney biopsy, the results for IgA nephropathy and IgA vasculitis will look very similar [3]. In both conditions, the biopsy shows deposits of an antibody called Immunoglobulin A (IgA) in the glomeruli (the filtering units of the kidneys) [1].

While researchers have noted some general trends—such as IgA nephropathy biopsies showing more chronic scarring, and IgA vasculitis biopsies showing more active inflammation or crescents (areas of active cellular inflammation in the filtering units, which can later lead to scarring)—these are only group tendencies, not strict rules [4]. A doctor cannot reliably diagnose one condition over the other based on a kidney biopsy alone [5]. Diagnosing primary IgA nephropathy requires doctors to first evaluate your medical history and run tests to rule out IgA vasculitis and other secondary causes [1].

The Key Differences in Symptoms

Because the kidneys look the same in both diseases, your doctor will look for extra-renal (non-kidney) symptoms that are the hallmarks of IgA vasculitis. These include:

  • Palpable purpura: This is a distinctive, raised, purple-red skin rash that doesn’t turn white when you press on it [2]. It is most commonly found on the lower legs and buttocks [1].
  • Joint pain or swelling: Arthralgia (joint pain) or arthritis (joint inflammation) is very common in IgA vasculitis [2].
  • Abdominal pain and GI bleeding: Severe, crampy abdominal pain, vomiting, or blood in the stool are critical signs of IgA vasculitis [6].

Urgent Symptoms Warning: If you experience severe or worsening abdominal pain, persistent vomiting, bloody or black stools, fainting, or marked abdominal swelling, seek immediate medical attention. While serious complications are uncommon, they require urgent assessment [2].

Timing can be tricky. While the purpura (rash) often leads to an earlier diagnosis of IgA vasculitis, kidney symptoms can sometimes appear before the rash [4]. In rare cases, the telltale rash may not appear until much later, but usually, it happens before or around the same time as other symptoms [5].

At a Glance: Comparing the Conditions

Feature Primary IgA Nephropathy IgA Vasculitis
Main Focus Limited mostly to the kidneys Systemic (affects multiple body systems)
Common Extra-Kidney Symptoms Usually none (sometimes visible blood in urine during a cold) Raised purple-red rash, joint pain/swelling, severe abdominal pain
Kidney Biopsy Shows IgA deposits; often more chronic scarring Shows IgA deposits; often more active inflammation (crescents)
Long-Term Monitoring Ongoing long-term kidney care Depends on kidney involvement; at least 6 months after a flare

Testing and Comprehensive Evaluation

When you have kidney findings like blood in the urine (hematuria) or protein in the urine (proteinuria), a full-body history and examination are vital [1]. No single blood test separates primary IgAN from IgAV, so your medical team will likely:

  • Perform a full physical exam: Doctors will specifically check your skin, joints, and abdomen for signs of systemic vasculitis [2].
  • Monitor blood and urine: Checking your blood pressure, estimated glomerular filtration rate (eGFR - a measure of kidney function), and the amount of protein in your urine helps doctors assess the severity of kidney involvement [7].
  • Help evaluate for secondary causes: Blood work can help evaluate if your symptoms might be related to other issues that cause IgA deposits, such as chronic liver disease, infections, or other autoimmune conditions [8].

How Management and Follow-Up Differ

Your long-term care will look different depending on your diagnosis. Note: Never change medication doses on your own, and do not start taking NSAIDs (like ibuprofen or naproxen) without asking your doctor, as these can worsen kidney function or GI bleeding.

Managing IgA Nephropathy:
Treatment focuses on long-term kidney protection. The main goals are lowering the amount of protein in your urine and keeping your blood pressure at an individualized target set by your doctor (often aiming for a top number below 120 mm Hg, if tolerated) [9]. This is usually done with lifestyle changes (like reducing dietary salt) and medications that protect the kidneys, such as ACE inhibitors or ARBs, and sometimes SGLT2 inhibitors if you meet specific clinical criteria [10]. Stronger medications that suppress the immune system are not for everyone; they are generally reserved for patients who remain at high risk of kidney decline despite initial supportive treatments [1].

Managing IgA Vasculitis:
Care for IgA vasculitis addresses both the systemic illness and the kidneys. Severe joint or gastrointestinal pain may require specific supportive care, specialist assessment, and sometimes carefully selected corticosteroid therapy [2]. Crucially, the kidney problems in IgA vasculitis can appear without noticeable symptoms many weeks after the initial skin rash or stomach pain has gone away [6]. For this reason, serial monitoring of your urine and blood pressure is highly recommended for at least six months after an IgA vasculitis flare [11]. If you do develop established kidney disease from IgA vasculitis, you will need ongoing, long-term nephrology follow-up, similar to primary IgA nephropathy.

Common questions in this guide

What is the main difference between IgA nephropathy and IgA vasculitis?
IgA nephropathy is usually limited to the kidneys. IgA vasculitis is a body-wide condition that can affect the skin, joints, digestive tract, and kidneys, so symptoms outside the kidneys are important clues.
Can a kidney biopsy tell these two conditions apart?
Not reliably. Both conditions can show IgA deposits in the kidney filters, and findings such as scarring or areas of active inflammation are general patterns rather than rules. Doctors combine the biopsy with your symptoms, medical history, and physical examination.
What symptoms make IgA vasculitis more likely?
A raised purple-red rash that does not turn white when pressed, especially on the legs or buttocks, is a key clue. Joint pain or swelling and severe crampy abdominal pain, vomiting, or blood in the stool also suggest IgA vasculitis. Kidney symptoms can occasionally occur before the rash.
Can kidney problems start after an IgA vasculitis rash goes away?
Yes. Kidney involvement can appear weeks after the rash or stomach symptoms have improved, sometimes without noticeable symptoms. Urine and blood pressure should be checked repeatedly for at least six months after a flare, and established kidney disease needs ongoing nephrology follow-up.
How does treatment differ for IgA nephropathy and IgA vasculitis?
IgA nephropathy care focuses on protecting kidney function by controlling blood pressure and urine protein, often with salt reduction and kidney-protective medicines such as ACE inhibitors or ARBs; some patients may qualify for SGLT2 inhibitors or immune-suppressing treatment. IgA vasculitis care also addresses skin, joint, and digestive symptoms, and severe symptoms may require corticosteroids and specialist care.
When should I get urgent medical help with possible IgA vasculitis?
Seek immediate medical attention for severe or worsening abdominal pain, persistent vomiting, bloody or black stools, fainting, or marked abdominal swelling. These symptoms can signal complications that need prompt assessment.

Get notified when new evidence is published on Immunoglobulin A nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    IgA Nephropathy in Adults: A Review.

    Stoneman S, Teh JW, O'Shaughnessy MM

    JAMA 2026; (335(9)):799-813 doi:10.1001/jama.2025.25020.

    PMID: 41587026
  2. 2

    IgA vasculitis.

    Pillebout E, Sunderkötter C

    Seminars in immunopathology 2021; (43(5)):729-738 doi:10.1007/s00281-021-00874-9.

    PMID: 34170395
  3. 3

    IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?

    Pillebout E

    Seminars in nephrology 2024; (44(5)):151571 doi:10.1016/j.semnephrol.2025.151571.

    PMID: 40069065
  4. 4

    Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.

    Friedrich J, Bellmann M, Klank D, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2024; (40(1)):182-192 doi:10.1093/ndt/gfae143.

    PMID: 38908911
  5. 5

    IgA Vasculitis and IgA Nephropathy: Same Disease?

    Pillebout E

    Journal of clinical medicine 2021; (10(11)) doi:10.3390/jcm10112310.

    PMID: 34070665
  6. 6

    [IgA vasculitis - similarities and differences to IgA nephropathy].

    Gadola SD

    Therapeutische Umschau. Revue therapeutique 2022; (79(5)):260-268 doi:10.1024/0040-5930/a001359.

    PMID: 35583021
  7. 7

    Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives.

    Sestan M, Jelusic M

    Pediatric health, medicine and therapeutics 2023; (14()):89-98 doi:10.2147/PHMT.S379862.

    PMID: 36915829
  8. 8

    Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.

    Zhao L, Peng L, Yang D, et al.

    Clinical immunology (Orlando, Fla.) 2020; (217()):108483 doi:10.1016/j.clim.2020.108483.

    PMID: 32479989
  9. 9

    IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy.

    Alobaidi S

    Diagnostics (Basel, Switzerland) 2026; (16(9)) doi:10.3390/diagnostics16091259.

    PMID: 42121963
  10. 10

    Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).

    Floege J, Barratt J, Cook HT, et al.

    Kidney international 2025; (108(4)):548-554 doi:10.1016/j.kint.2025.04.003.

    PMID: 40975525
  11. 11

    Biomarkers to predict kidney outcomes in children with IgA vasculitis.

    Williams CEC, Ging H, Skoutelis N, et al.

    Minerva pediatrics 2025; (77(3)):256-271 doi:10.23736/S2724-5276.24.07715-2.

    PMID: 40131233

This comparison is for informational purposes only and does not constitute medical advice. Your nephrologist and healthcare team can interpret your biopsy, symptoms, and monitoring plan.